The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers T Pohjalainen, JO Rinne, K Någren, P Lehikoinen, K Anttila, ... Molecular psychiatry 3 (3), 256-260, 1998 | 844 | 1998 |
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, ... Lancet (London, England) 346 (8983), 1130-1131, 1995 | 430 | 1995 |
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence J Hietala, C West, E Syvälahti, K Någren, P Lehikoinen, P Sonninen, ... Psychopharmacology 116, 285-290, 1994 | 336 | 1994 |
Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior T Hallikainen, T Saito, HM Lachman, J Volavka, T Pohjalainen, ... Molecular psychiatry 4 (4), 385-388, 1999 | 327 | 1999 |
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, ... Schizophrenia research 35 (1), 41-50, 1999 | 319 | 1999 |
Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo T Pohjalainen, JO Rinne, K Någren, E SyvÄlahti, J Hietala American Journal of Psychiatry 155 (6), 768-773, 1998 | 312 | 1998 |
Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism J Tiihonen, T Hallikainen, H Lachman, T Saito, J Volavka, J Kauhanen, ... Molecular psychiatry 4 (3), 286-289, 1999 | 269 | 1999 |
Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography J Hietala, E Syvälahti, K Vuorio, K Nägren, P Lehikoinen, U Ruotsalainen, ... Archives of general psychiatry 51 (2), 116-123, 1994 | 249 | 1994 |
Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride JO Rinne, J Hietala, U Ruotsalainen, E Säkö, A Laihinen, K Någren, ... Journal of Cerebral Blood Flow & Metabolism 13 (2), 310-314, 1993 | 244 | 1993 |
Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? V Lehtinen, J Aaltonen, T Koffert, V Räkköläinen, E Syvälahti European psychiatry 15 (5), 312-320, 2000 | 243 | 2000 |
Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor EP Pälvimäki, H Majasuo, A Laakso, M Kuoppamäki, E Syvälahti, BL Roth, ... Psychopharmacology 126, 234-240, 1996 | 235 | 1996 |
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects A Laakso, H Vilkman, J Örgen Bergman, M Haaparanta, O Solin, ... Biological psychiatry 52 (7), 759-763, 2002 | 232 | 2002 |
Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind … BG Appelberg, EK Syvalahti, TE Koskinen, OP Mehtonen, TT Muhonen, ... Journal of Clinical Psychiatry 62 (6), 448-452, 2001 | 212 | 2001 |
The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects A Laakso, T Pohjalainen, J Bergman, J Kajander, M Haaparanta, O Solin, ... Pharmacogenetics and genomics 15 (6), 387-391, 2005 | 211 | 2005 |
Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists M Kuoppamäki, E Syvälahti, J Hietala European Journal of Pharmacology: Molecular Pharmacology 245 (2), 179-182, 1993 | 162 | 1993 |
Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography A Laakso, H Vilkman, B Alakare, M Haaparanta, J Bergman, O Solin, ... American Journal of Psychiatry 157 (2), 269-271, 2000 | 160 | 2000 |
Personality traits and striatal dopamine synthesis capacity in healthy subjects A Laakso, E Wallius, J Kajander, J Bergman, O Eskola, O Solin, T Ilonen, ... American Journal of Psychiatry 160 (5), 904-910, 2003 | 143 | 2003 |
Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia A Laakso, J Bergman, M Haaparanta, H Vilkman, O Solin, E Syvälahti, ... Schizophrenia research 52 (1-2), 115-120, 2001 | 142 | 2001 |
The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients CC Joyal, MP Laakso, J Tiihonen, E Syvälahti, H Vilkman, A Laakso, ... Biological psychiatry 54 (11), 1302-1304, 2003 | 120 | 2003 |
Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man S Aalto, J Ihalainen, J Hirvonen, J Kajander, H Scheinin, H Tanila, ... Psychopharmacology 182, 375-383, 2005 | 119 | 2005 |